All Clinical Trials

Clinical Trial NCT04729907

A Long-Term Extension Study of Nusinersen (BIIB058) Administered at Higher Doses in Participants With Spinal Muscular Atrophy Who Previously Participated in an Investigational Study With Nusinersen

  • ClinicalTrials.gov ID: NCT04729907
  • Not accepting healthy volunteers
  • UTSW Principal Investigator: SUSAN THERESA IANNACCONE

objective

To evaluate the long-term safety and tolerability of nusinersen administered intrathecally at higher doses to participants with SMA who previously participated in Study 203. To evaluate the long-term efficacy of nusinersen administered intrathecally at higher doses to participants with SMA who previously participated in Study 203.

If you are interested in this clinical trial, please contact Tammy Ramm on the Children’s Health Research Team.Call 214-456-4426Email